Trial intelligence / Profile preview

Azithromycin immunomodulation in pediatric recurrent pneumonia with mannose-binding lectin deficiency

2012-001766-15Phase 4Completed

Sponsor
Fundación Pública Andaluza para la Gestión de la Investigación
Start
Aug 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of azithromycin in pneumonia and mannose-binding lectin deficiency (2 arms), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Primary endpoint: Inflammatory marker quantification. Started Aug 2012; status: completed.

02

Drugs

azithromycin
03

Conditions

pneumoniamannose-binding lectin deficiency

Beyond the preview

Go deeper on 2012-001766-15.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2012-001766-15.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call